Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rocket Pharmaceuticals (RCKT) Amortization - Intangibles: 2018-2025

Historic Amortization - Intangibles for Rocket Pharmaceuticals (RCKT) over the last 7 years, with Sep 2025 value amounting to $1.7 million.

  • Rocket Pharmaceuticals' Amortization - Intangibles fell 9.19% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 million, marking a year-over-year decrease of 27.82%. This contributed to the annual value of $8.1 million for FY2024, which is 24.16% down from last year.
  • According to the latest figures from Q3 2025, Rocket Pharmaceuticals' Amortization - Intangibles is $1.7 million, which was down 24.37% from $2.2 million recorded in Q2 2025.
  • Rocket Pharmaceuticals' Amortization - Intangibles' 5-year high stood at $3.3 million during Q4 2023, with a 5-year trough of -$801,000 in Q4 2021.
  • Over the past 3 years, Rocket Pharmaceuticals' median Amortization - Intangibles value was $2.2 million (recorded in 2024), while the average stood at $2.3 million.
  • Per our database at Business Quant, Rocket Pharmaceuticals' Amortization - Intangibles tumbled by 1,130.65% in 2021 and then skyrocketed by 1,560.90% in 2023.
  • Rocket Pharmaceuticals' Amortization - Intangibles (Quarterly) stood at -$801,000 in 2021, then soared by 234.96% to $1.1 million in 2022, then spiked by 202.96% to $3.3 million in 2023, then tumbled by 62.66% to $1.2 million in 2024, then decreased by 9.19% to $1.7 million in 2025.
  • Its Amortization - Intangibles stands at $1.7 million for Q3 2025, versus $2.2 million for Q2 2025 and $2.2 million for Q1 2025.